Freenome Reports Strong SimpleScreen CRC Study Results
BRISBANE, Calif. | July 9, 2026 Freenome, an early cancer detection company advancing blood-based cancer screening technologies, has announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BRISBANE, Calif. | July 9, 2026 Freenome, an early cancer detection company advancing blood-based cancer screening technologies, has announced...
CARLSBAD, California, July 2, 2026 Arima Genomics, Inc., a cancer diagnostics company advancing precision oncology through Hi-C sequencing technology,...
CARLSBAD, Calif., July 2, 2026 Arima Genomics, Inc. announced an exclusive distribution partnership with Active Motif Incorporated, granting the...
RAHWAY, New Jersey | January 7, 2026 — Merck has completed its acquisition of Cidara Therapeutics, marking a significant...
BRISBANE, California | January 7, 2026 — CareDx and 10x Genomics have announced the launch of ImmuneScape™, a multiomics...
October 14, 2025 | Dallas, TX & Aurora, CO — Verily, UCHealth, the University of Colorado Anschutz, and RefinedScience...
